lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
1,151 rows where filing_year = 2019 and issue_code = "MED" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: filing_type, is_termination, received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2260501 | LIBERTY GOVERNMENT AFFAIRS 8efe606c-3b0f-4b86-8cb6-322468880539 | 1T | LIBERTY GOVERNMENT AFFAIRS | 401104531 | WEEDMAPS | 2019 | first_quarter | MED | Medical marijuana research. | HOUSE OF REPRESENTATIVES,SENATE | 5000 | 0 | 1 | 2019-02-01T11:14:41.910000-05:00 | |
| 2260526 | BROWN RUDNICK LLP cd42d749-9ef3-41f7-97f9-3bcb1763e948 | 1T | BROWN RUDNICK LLP | 287895 | HOOPER LUNDY & BOOKMAN P C (OBO ROCHE DIAGNOSTICS) | 2019 | first_quarter | MED | The Verifying Accurate Leading-edge IVCT Development Act. | HOUSE OF REPRESENTATIVES,SENATE | 5000 | 0 | 1 | 2019-02-08T15:40:19.023000-05:00 | |
| 2260639 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 5797c503-46cb-4ec1-83c1-311af7a761b9 | 1T | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | 23ANDME, INC. | 2019 | first_quarter | MED | Data Privacy, consumer genomics | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 1 | 2019-03-08T14:44:42.757000-05:00 | |
| 2260828 | REPUBLIC CONSULTING, LLC aeb33366-a4de-4c70-9877-d780ea2a8637 | Q1 | REPUBLIC CONSULTING, LLC | 401016871 | IQVIA | 2019 | first_quarter | MED | Monitor Data and Science policy. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2019-03-30T12:58:06.777000-04:00 | |
| 2260859 | AUBURN HEALTH STRATEGIES, LLC 01e79168-b068-402c-af6f-bdd84a7fe92b | Q1 | AUBURN HEALTH STRATEGIES, LLC | 292697 | NEUROTECH, LLC | 2019 | first_quarter | MED | EEG monitoring | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2019-03-30T22:41:37.510000-04:00 | ||
| 2260903 | FRANCIS EDWARD & CRONIN, INC. 55b6e8d8-571b-48de-90a5-3e2a5a68fd49 | Q1 | FRANCIS EDWARD & CRONIN, INC. | 311314 | CURE ALZHEIMER'S FUND | 2019 | first_quarter | MED | Issues and legislation related to Alzheimer's disease research | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE | 20000 | 0 | 0 | 2019-04-01T08:31:40.857000-04:00 | |
| 2260905 | FRANCIS EDWARD & CRONIN, INC. f582ce28-d171-4fdd-b31a-68d91d779105 | Q1 | FRANCIS EDWARD & CRONIN, INC. | 311314 | PATH DECISION SUPPORT SOFTWARE, LLC | 2019 | first_quarter | MED | Issues and legislation related to diabetes treatment and diagnosis | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 0 | 0 | 2019-04-01T08:34:42.423000-04:00 | ||
| 2260986 | OTT BIELITZKI & O'NEILL PLLC d275bae6-2a46-4a48-ac05-389154d8ab3e | Q1 | OTT BIELITZKI & O'NEILL PLLC | 401103584 | BIOPORTO DIAGNOSTICS A/S | 2019 | first_quarter | MED | Educating officials about a health care diagnostic tool. | Agriculture, Dept of (USDA),Defense, Dept of (DOD),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2019-04-01T13:32:00.060000-04:00 | |
| 2261333 | MCDERMOTT WILL & SCHULTE LLP 6dc3c207-e58a-45e8-9c02-09833450a29e | Q1 | MCDERMOTT WILL & SCHULTE LLP | 24338 | ABIOMED, INC. | 2019 | first_quarter | MED | Issues related to Medicare reimbursement and the medical device tax. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2019-04-03T09:41:09.097000-04:00 | |
| 2261347 | RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) 0bf07e14-c6d7-45df-9341-0877ec2438f3 | Q1 | RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC) | 400361684 | PPLA | 2019 | first_quarter | MED | Pharmaceutical labeling | Food & Drug Administration (FDA) | 18700 | 0 | 0 | 2019-04-03T10:29:21.487000-04:00 | |
| 2261359 | WAKE FOREST UNIVERSITY HEALTH SCIENCES d8f9fe31-e563-44a5-90f6-9017870e08fc | Q1 | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 6781 | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 2019 | first_quarter | MED | VA Research funding and access; VA Missions Act implementation; FY 2020 President's Budget Request for VA Research Programs; Higher Education Act reauthorization; animal research legislation; FY 2020 President's Budget Request for Departments of Labor/HHS; | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 150000 | 0 | 0 | 2019-04-03T10:59:32.273000-04:00 | |
| 2261408 | MR. BRIAN KELLY 8058f3de-b187-44a2-bf72-9b4241adf05c | Q1 | MR. BRIAN KELLY | 40024191 | INTELLIA THERAPEUTICS | 2019 | first_quarter | MED | WHO Gene Editing Summit | Defense Advanced Research Projects Agency (DARPA),Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE,White House Office | 15000 | 0 | 0 | 2019-04-03T12:18:50.910000-04:00 | |
| 2261631 | JUSTICE FOR JAKE fbdf6fbe-9936-42b4-8440-c2b3c2305fc9 | Q1 | JUSTICE FOR JAKE | 401104713 | JUSTICE FOR JAKE | 2019 | first_quarter | MED | Project Vision - Overdose death decrease | Office of the Vice President of the United States,President of the U.S.,White House Office | 0 | 0 | 2019-04-04T10:20:23.280000-04:00 | ||
| 2261760 | AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION ed38ec67-d7b7-4760-be8c-ebad0321dd6e | Q1 | AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION | 401103437 | AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY ASSOCIATION | 2019 | first_quarter | MED | Medicare Advantage Plans on Prior Authorization | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 0 | 0 | 2019-04-04T14:11:45.137000-04:00 | ||
| 2261789 | FAEGRE DRINKER BIDDLE & REATH LLP 8f68fab7-890e-488f-84a7-bc181f6045bc | Q1 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTH | 2019 | first_quarter | MED | H.R. 6378 Pandemic All Hazards Preparedness Act Reauthorization; S. 2852 Pandemic and All Hazards Preparedness and Advancing Innovation Act; P.L. 115-411 Implementation of Global Health Innovation Act. | HOUSE OF REPRESENTATIVES | 20000 | 0 | 0 | 2019-04-04T14:47:03.670000-04:00 | |
| 2261793 | FAEGRE DRINKER BIDDLE & REATH LLP 4e42acb1-518a-4e4a-8647-95589203082b | Q1 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | DRUGS FOR NEGLECTED DISEASES INITIATIVE OF NORTH AMERICA | 2019 | first_quarter | MED | Neglected Tropical Disease Research and Development; H.R. 6378, Pandemic and All Hazards Preparedness Act Re-authorization; S. 2852, Pandemic and All Hazards Preparedness and Advancing Innovation Act. | 10000 | 0 | 0 | 2019-04-04T14:50:06.830000-04:00 | ||
| 2261797 | FAEGRE DRINKER BIDDLE & REATH LLP 2f124b13-134a-402f-9171-a943839c5367 | Q1 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE | 2019 | first_quarter | MED | Public Health Programs for Infectious and Tropical Disease and Anti-Microbial Resistance; NIH Research; H.R. 6378 Pandemic and All Hazards Preparedness Reauthorization; S. 2852 Pandemic and All Hazards Preparedness and Advancing Innovation Act; H. Res 214 Supporting the goals to protect U.S. military personnel from malaria. | Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2019-04-04T14:51:07.567000-04:00 | |
| 2261970 | NEOGENOMICS LABORATORIES 40eb34b0-cfb4-4026-b997-12a9cc4c17e1 | Q1 | NEOGENOMICS LABORATORIES | 401105014 | NEOGENOMICS LABORATORIES | 2019 | first_quarter | MED | Diagnostic Accuracy and Innovation Act | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 45000 | 0 | 0 | 2019-04-05T09:01:48.090000-04:00 | |
| 2262008 | THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH 1647f2c7-f0c6-4949-ba00-2998d6e9452d | Q1 | THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH | 314055 | THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH | 2019 | first_quarter | MED | Support for Medical Research Funding Programs at the National Institutes of Health, the National Eye Institute, and the Department of Defense | HOUSE OF REPRESENTATIVES,SENATE | 63232 | 0 | 0 | 2019-04-05T10:55:09.827000-04:00 | |
| 2262164 | NATIONAL MULTIPLE SCLEROSIS SOCIETY b00670ee-5858-4b25-aee7-ac66f40bc007 | Q1 | NATIONAL MULTIPLE SCLEROSIS SOCIETY | 69674 | NATIONAL MULTIPLE SCLEROSIS SOCIETY | 2019 | first_quarter | MED | N/A | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 108346 | 0 | 0 | 2019-04-05T15:27:48.200000-04:00 | |
| 2262315 | NATURAL RESOURCE RESULTS LLC 70c37d0a-80fb-4417-9116-095752b76c86 | Q1 | NATURAL RESOURCE RESULTS LLC | 321555 | SHINE MEDICAL TECHNOLOGIES | 2019 | first_quarter | MED | Support budget and approps for grants to cooperatives on medical isotope MO-99 production facility. | Energy, Dept of,HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 10000 | 0 | 0 | 2019-04-07T11:11:04.240000-04:00 | |
| 2262338 | MARSHALL BRACHMAN f0dbe498-338c-4ad2-aa19-a90e006e85a4 | Q1 | MARSHALL BRACHMAN | 6848 | BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM | 2019 | first_quarter | MED | support funding for medical research programs | HOUSE OF REPRESENTATIVES,SENATE | 33000 | 0 | 0 | 2019-04-07T15:21:22.620000-04:00 | |
| 2262375 | AUBURN HEALTH STRATEGIES, LLC 619ee755-dbca-41cd-bc71-0fc91e938c0e | Q1 | AUBURN HEALTH STRATEGIES, LLC | 292697 | API GROUP (FORMERLY KNOWN AS API FOOD QUALITY INC ) | 2019 | first_quarter | MED | quality of laboratory testing | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2019-04-07T20:32:45.307000-04:00 | ||
| 2262390 | FAEGRE DRINKER BIDDLE & REATH LLP 6c4b4498-c655-42da-9b00-7be4cc9b090e | Q1 | FAEGRE DRINKER BIDDLE & REATH LLP | 12631 | PREECLAMPSIA FOUNDATION | 2019 | first_quarter | MED | Preeclampsia Research Issues. | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 10000 | 0 | 0 | 2019-04-08T09:38:04.293000-04:00 | |
| 2262443 | MCDERMOTT+ LLC 27d4a464-5a94-403b-808a-528b7b229624 | Q1 | MCDERMOTT+ LLC | 401103287 | COALITION FOR 21ST CENTURY MEDICINE | 2019 | first_quarter | MED | Issues concerning regulation of laboratory-developed tests. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 40000 | 0 | 0 | 2019-04-08T11:26:44.167000-04:00 | |
| 2262626 | IPOLICY SOLUTIONS 7f287f7e-5114-4835-a962-3e6185efde25 | Q1 | IPOLICY SOLUTIONS | 401105127 | 23ANDME, INC. | 2019 | first_quarter | MED | No bill # Verifying Accurate Leading-Edge IVCT Development (VALID) Act | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2019-04-08T15:15:35.550000-04:00 | |
| 2262637 | IPOLICY SOLUTIONS 9bc0a658-7a3f-4a25-8150-96dfdbca70a6 | Q1 | IPOLICY SOLUTIONS | 401105127 | ASSOCIATION FOR MOLECULAR PATHOLOGY | 2019 | first_quarter | MED | No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2019-04-08T15:24:45.983000-04:00 | |
| 2262652 | IPOLICY SOLUTIONS 35518392-6ce4-4c62-a986-1ff4d3d10d5e | Q1 | IPOLICY SOLUTIONS | 401105127 | INVITAE INC. | 2019 | first_quarter | MED | No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2019-04-08T15:35:54.170000-04:00 | |
| 2262716 | IPOLICY SOLUTIONS 10cf70d8-c4df-493d-875d-090790e30e1a | Q1 | IPOLICY SOLUTIONS | 401105127 | SEMA4 (FORMERLY KNOWN AS MOUNT SINAI GENOMICS, INC. (D/B/A SEMA4)) | 2019 | first_quarter | MED | No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act Draft Guidance: Developing and Labeling In vitro Companion Diagnostic Devices for a Specific Group or Class of Oncology Therapeutic Products | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2019-04-08T18:00:16.177000-04:00 | |
| 2262754 | AMERICAN COLLEGE OF CLINICAL PHARMACY d34f67f2-7da7-455b-b142-9f4b17f1ca1e | Q1 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2019 | first_quarter | MED | Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 144981 | 0 | 0 | 2019-04-09T09:12:15.970000-04:00 | |
| 2262886 | UC HEALTH 35077f33-fe7b-4a20-b0a0-080de7851d81 | Q1 | UC HEALTH | 401103195 | UC HEALTH | 2019 | first_quarter | MED | Research, NIH funding | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2019-04-09T13:02:53.750000-04:00 | ||
| 2263622 | TCH GROUP, LLC 7604579d-522d-43fc-b67f-9a519ebb10d1 | Q1 | TCH GROUP, LLC | 51478 | INTERNATIONAL AIDS VACCINE INITIATIVE | 2019 | first_quarter | MED | FY 19 Consolidated Appropriations Act (HJ Res 31/ PL 116-6) and FY 20 State Foreign Operations Subcommittee Appropriations bills. Specifically, continued Federal funding under USAID for AIDS vaccine research and development. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2019-04-10T15:58:10.493000-04:00 | |
| 2263732 | BROYDRICK & ASSOCIATES d2390970-88ce-41bf-9adc-f1177679e358 | Q1 | BROYDRICK & ASSOCIATES | 7268 | EXACT SCIENCES | 2019 | first_quarter | MED | Health Care Reform. HR 4872 to expedite FDA/CMS approval process for cancer screening test. Work on VA and Tricare acceptance of new technologies. USPSTF approvals. Legislation on cancer screening test process. Interpretation of section 2713 of the Affordable Healthcare Act. American Healthcare Act. DEA Acceptance. | Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2019-04-10T21:34:22.110000-04:00 | ||
| 2263968 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 506c1453-4da6-4718-929d-e490371677d4 | Q1 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | TUBEROUS SCLEROSIS ALLIANCE | 2019 | first_quarter | MED | FY20 Defense Appropriations, Peer-Reviewed Medical Research Program FY20 Labor, HHS, NIH | Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2019-04-11T11:53:02.307000-04:00 | |
| 2263982 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 2522e604-e3ab-4935-bcff-e87998f62051 | Q1 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | PANCREATIC CANCER ACTION NETWORK (PANCAN) | 2019 | first_quarter | MED | cancer research at DOD and NIH FY20 Defense Appropriations, Peer-Reviewed Medical Research Program FY20 Labor-HHS-Education Appropriations Act, NIH | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 40000 | 0 | 0 | 2019-04-11T12:01:07.363000-04:00 | |
| 2263997 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 84a0ffb0-8534-4e3a-bdf9-b641f68a4e79 | Q1 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | AMERICAN SOCIETY OF HEMATOLOGY | 2019 | first_quarter | MED | Research in hematology | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2019-04-11T12:11:13.627000-04:00 | |
| 2264026 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. d9c94825-b406-4525-b6e3-e47580042fa7 | Q1 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | NATIONAL ASSOCIATION OF EPILEPSY CENTERS | 2019 | first_quarter | MED | Research and public health programs in epilepsy. | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 10000 | 0 | 0 | 2019-04-11T12:21:24.703000-04:00 | |
| 2264092 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. e1e3d1b3-3a53-484f-879e-313d04127c66 | Q1 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | ENDOCRINE SOCIETY | 2019 | first_quarter | MED | Research in Endocrinology, Standardization of Hormone Testing | Centers For Medicare and Medicaid Services (CMS),Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2019-04-11T12:55:49.387000-04:00 | |
| 2264227 | LNE GROUP eaaa65a7-35cb-479b-9146-4662120df975 | Q1 | LNE GROUP | 308811 | HOSPICE OF THE WESTERN RESERVE | 2019 | first_quarter | MED | lobbied for medical issues | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) | 10000 | 0 | 0 | 2019-04-11T15:15:53.050000-04:00 | |
| 2264241 | LNE GROUP 6dc00d59-152e-4774-93e5-70554614f036 | Q1 | LNE GROUP | 308811 | OHIOGUIDESTONE (FORMALLY KNOWN AS GUIDESTONE) | 2019 | first_quarter | MED | lobbied for medical issues | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2019-04-11T15:27:58.580000-04:00 | |
| 2264251 | INTUITIVE SURGICAL, INC. 51814481-ff6b-4299-85bb-93ca94b06762 | Q1 | INTUITIVE SURGICAL, INC. | 400670004 | INTUITIVE SURGICAL, INC. | 2019 | first_quarter | MED | comparative effectiveness research in healthcare | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2019-04-11T15:33:01.307000-04:00 | |
| 2264274 | LNE GROUP edd0e94d-e3c5-45ce-a085-1da5a21a580e | Q1 | LNE GROUP | 308811 | PARKER HANNIFIN | 2019 | first_quarter | MED | lobbied on medical issues | HOUSE OF REPRESENTATIVES,SENATE,U.S. Coast Guard (USCG) | 80000 | 0 | 0 | 2019-04-11T15:39:05.987000-04:00 | |
| 2264385 | ATLAS ADVOCACY b6b03d04-816d-4a24-a157-632f2dc6ccb7 | Q1 | ATLAS ADVOCACY | 401100069 | BLADDER CANCER ADVOCACY NETWORK | 2019 | first_quarter | MED | CDMRP; Disease Awreness resolution | HOUSE OF REPRESENTATIVES,SENATE | 8500 | 0 | 0 | 2019-04-11T17:27:57.967000-04:00 | |
| 2264489 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. aa100c1f-7338-4eeb-b3b3-2c2e3a65f4aa | 1A | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | FOUNDATION FOR PERIPHERAL NEUROPATHY | 2019 | first_quarter | MED | FY20 Defense Appropriations, Peer-Reviewed Medical Research Program FY20 Labor, HHS, NIH | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2019-04-12T08:58:55.207000-04:00 | ||
| 2264507 | UPSTREAM CONSULTING, INC. fcbdbcf5-c6db-4558-9917-bf786532c336 | Q1 | UPSTREAM CONSULTING, INC. | 88278 | RARE ACCESS ACTION PROJECT | 2019 | first_quarter | MED | Coverage for rare disease therapies. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2019-04-12T09:44:05.627000-04:00 | ||
| 2264512 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER ed4c2a27-d660-4889-94da-cc9bed4acc76 | Q1 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER | 312496 | CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER | 2019 | first_quarter | MED | NIH Budget, PCORI re authorization, NICHD budget, sickle cell research, CHGME, ACE Act for kids | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office | 40568 | 0 | 0 | 2019-04-12T10:03:07.977000-04:00 | |
| 2264565 | FAMILIES USA FOUNDATION, INC. 76b93e3f-8c0f-4e58-b938-9688d97b6693 | Q1 | FAMILIES USA FOUNDATION, INC. | 14108 | FAMILIES USA FOUNDATION INC | 2019 | first_quarter | MED | S.184Gun Violence Prevention Research Act - authorize the appropriation of funds to the Centers for Disease Control and Prevention for conducting or supporting research on firearms safety or gun violence prevention | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2019-04-12T10:55:30.653000-04:00 | |
| 2264876 | 60 PLUS ASSOCIATION 9e596569-74d8-4933-9fea-a300b671bb52 | Q1 | 60 PLUS ASSOCIATION | 41988 | 60 PLUS ASSOCIATION | 2019 | first_quarter | MED | Support the Right to Try Act | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office | 0 | 0 | 2019-04-12T14:45:35.763000-04:00 | ||
| 2264943 | THE CJR GROUP, INC. 74eda7be-9168-49ca-9c82-02589bc31181 | Q1 | THE CJR GROUP, INC. | 288293 | UNIVERSITY HOSPITALS HEALTH SYSTEM | 2019 | first_quarter | MED | NIH funding, mental health initiatives | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2019-04-12T15:29:58.990000-04:00 | |
| 2264957 | MUNK POLICY & LAW 4efc937f-ef78-4cdf-ba41-efc7ed8241e5 | Q1 | MUNK POLICY & LAW | 401105075 | SOUTHERN METHODIST UNIVERSITY | 2019 | first_quarter | MED | Traumatic Brain injury Research | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2019-04-12T15:39:05.173000-04:00 | |
| 2265166 | MOLNLYCKE HEALTH CARE US, LLC 2479c5b1-cb87-4aab-9235-644d2c5c2f5c | Q1 | MOLNLYCKE HEALTH CARE US, LLC | 401104898 | MOLNLYCKE HEALTH CARE US, LLC | 2019 | first_quarter | MED | Pursuance of approval from relevant agencies of a medical pilot program; gathering support from Congressional leaders. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2019-04-14T12:52:41.547000-04:00 | |
| 2265197 | COMMONWEALTH POLICY SOLUTIONS fe078d36-aaed-4a1c-81be-15edd16b7503 | Q1 | COMMONWEALTH POLICY SOLUTIONS | 401105004 | TRISALUS LIFE SCIENCES | 2019 | first_quarter | MED | Medical device development for oncology, drug delivery for oncology | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2019-04-14T13:18:49.537000-04:00 | |
| 2265198 | COMMONWEALTH POLICY SOLUTIONS 7285dfe7-440f-4921-ab01-20f2a99e3bdc | Q1 | COMMONWEALTH POLICY SOLUTIONS | 401105004 | RARE ACCESS ACTION PROJECT | 2019 | first_quarter | MED | Reimbursement for rare disease patient care | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2019-04-14T13:20:50.227000-04:00 | ||
| 2265828 | THE CONSILIO GROUP 8aa87597-39d5-483f-9bc5-921c1f27b7b6 | Q1 | THE CONSILIO GROUP | 400374717 | MADEN TECH CONSULTING, INC. | 2019 | first_quarter | MED | Infrastructure rebuilding. | Federal Emergency Management Agency (FEMA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE | 6000 | 0 | 0 | 2019-04-15T13:51:11.077000-04:00 | |
| 2265942 | FEDERAL SOLUTIONS, LLC 5568accc-1545-465d-ae36-ba96331df988 | Q1 | FEDERAL SOLUTIONS, LLC | 311371 | MISSISSIPPI STATE UNIVERSITY | 2019 | first_quarter | MED | Labor/HHS/Education Appropriations: Provisions relating to disease research. | Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE | 50000 | 0 | 0 | 2019-04-15T14:35:51.647000-04:00 | |
| 2266482 | THE PETRIZZO GROUP, INC. d918af09-ad5f-4e97-8b33-223b3c70be8f | Q1 | THE PETRIZZO GROUP, INC. | 305932 | ALLEN INSTITUTE | 2019 | first_quarter | MED | Advocated for funding of the BRAIN Initiative, Alzheimer's research full funding for NIH. Advocated for the development of open data hosting, and integrated, scalable data analysis hubs for the BRAIN Initiative at NIH. | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 20000 | 0 | 0 | 2019-04-15T23:31:22.277000-04:00 | |
| 2266490 | THE PETRIZZO GROUP, INC. f3aabc08-b910-4c26-b0da-03d3f575dbb4 | Q1 | THE PETRIZZO GROUP, INC. | 305932 | OMEROS CORPORATION | 2019 | first_quarter | MED | Advocated for Medicare Part B packaged payment reforms. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Office of the Vice President of the United States,SENATE,Vice President of the U.S.,White House Office | 100000 | 0 | 0 | 2019-04-15T23:41:24.630000-04:00 | |
| 2266504 | THE PETRIZZO GROUP, INC. ecb60f5a-c3ee-4b79-b3c4-245e401b943d | Q1 | THE PETRIZZO GROUP, INC. | 305932 | UNITED BIOMEDICAL, INC. | 2019 | first_quarter | MED | Advocated for federal funding and development of robust vaccine research for Alzheimer's, Parkinson's and other neurological diseases. | Agriculture, Dept of (USDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institute of Mental Health (NIMH),Natl Institutes of Health (NIH),SENATE,White House Office | 50000 | 0 | 0 | 2019-04-15T23:53:28.657000-04:00 | |
| 2266848 | SQUIRE PATTON BOGGS 581baea6-3726-4e73-9319-5c742674d52f | Q1 | SQUIRE PATTON BOGGS | 30906 | ALLIANCE FOR BIOSECURITY | 2019 | first_quarter | MED | Preparedness and response as it relates to Biosecurity. | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 80000 | 0 | 0 | 2019-04-16T11:13:32.880000-04:00 | |
| 2266896 | O'NEILL AND ASSOCIATES 73f8789c-015c-41ba-a84f-831d3c07c376 | Q1 | O'NEILL AND ASSOCIATES | 73134 | POINT32HEALTH SERVICES, INC. (FORMERLY TUFTS HEALTH PLAN) | 2019 | first_quarter | MED | Medical | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2019-04-16T11:19:53.293000-04:00 | |
| 2266970 | SQUIRE PATTON BOGGS 4370ef50-fc7b-4ca0-8d9a-bea51c6654b8 | Q1 | SQUIRE PATTON BOGGS | 30906 | IMPACT JOURNALS, LLC | 2019 | first_quarter | MED | National Library of Medicine publication and archive matters. | HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 50000 | 0 | 0 | 2019-04-16T11:44:34.283000-04:00 | |
| 2267005 | SQUIRE PATTON BOGGS fcd0783e-ee83-4265-8203-1a67f2df1e84 | Q1 | SQUIRE PATTON BOGGS | 30906 | MOLNLYCKE HEALTH CARE US, LLC | 2019 | first_quarter | MED | Working with government officials to improve pressure ulcer reimbursement and awareness and other hospital acquired conditions. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2019-04-16T11:54:58.853000-04:00 | |
| 2267330 | WINNING STRATEGIES WASHINGTON b1bb7f36-1a4e-40b2-a3a0-febf486eb71b | Q1 | WINNING STRATEGIES WASHINGTON | 50796 | LAHEY HEALTH | 2019 | first_quarter | MED | Medicare reform | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2019-04-16T13:32:26.300000-04:00 | |
| 2267378 | ALEXANDER J. BECKLES, L.L.C. 9f6638fd-1db5-4d88-a968-5fe8fdf1c570 | Q1 | ALEXANDER J. BECKLES, L.L.C. | 40038308 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2019 | first_quarter | MED | H.R. 6505 - Medicare Negotiation and Competitive Licensing Act of 2018; Medicare Part D | HOUSE OF REPRESENTATIVES | 5000 | 0 | 0 | 2019-04-16T13:42:37.730000-04:00 | |
| 2267487 | BRACEWELL LLP 42c2ffa2-276a-4e4f-9d0d-0d019bcc970f | Q1 | BRACEWELL LLP | 6837 | AIR LIQUIDE USA LLC | 2019 | first_quarter | MED | work related to medical gases | Bureau of Land Management (BLM),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),Internal Revenue Service (IRS),SENATE,Treasury, Dept of | 84000 | 0 | 0 | 2019-04-16T14:25:01.457000-04:00 | |
| 2267761 | UNIVERSITY OF MIAMI 0a4c7796-8482-47f2-a58f-17254ba8dec1 | Q1 | UNIVERSITY OF MIAMI | 39462 | UNIVERSITY OF MIAMI | 2019 | first_quarter | MED | Fire Fighter Cancer | Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE | 93000 | 0 | 0 | 2019-04-16T15:28:45.467000-04:00 | |
| 2267802 | AMERICAN SOCIETY OF ADDICTION MEDICINE cf45cc9f-f526-4f34-a3eb-9835b2ea9d09 | Q1 | AMERICAN SOCIETY OF ADDICTION MEDICINE | 401104864 | AMERICAN SOCIETY OF ADDICTION MEDICINE | 2019 | first_quarter | MED | FY2020 Labor HHS Appropriations bill - appropriations related to strengthening the addiction services workforce, including full funding of the loan repayment program for the substance use disorder treatment workforce authorized in the SUPPORT Act, the mental and substance use disorders training demonstration program authorized in 21st Century Cures Act, and preventive medicine residency programs Re-introduction and modifications of the Corrections Public Health and Community Re-entry Act of 2018 - authorizes the National Institute of Corrections to make grants to, and enter cooperative agreements with, state and local governments to develop, implement, or expand medication-assisted treatment for incarcerated individuals who are addicted to opioids. Re-introduction and modifications of the Comprehensive Addiction Resources Emergency Act - to provide emergency assistance to States, territories, Tribal nations, and local areas affected by the opioid epidemic and to make financial assistance available to States, territories, Tribal nations, local areas, and public or private nonprofit entities to provide for the development, organization, coordination, and operation of more effective and cost efficient systems for the delivery of essential services to individuals with substance use disorder and their families. Advocated for additional evidence-based standards. Re-introduction of the Opioid Workforce Act of 2018 - bill increases the number of residency positions eligible for graduate medical education payments under Medicare for hospitals that have addiction or pain management programs, with an aggregate increase of 1,000 positions over a five-year period. Re-introduction of the Behavioral Health Coverage Transparency Act which would require issuers to disclose the analysis they perform in making parity determinations; require federal regulators to conduct random audits; and require the federal parity agencies to review denial rates for mental health versus medical claims. Additionally, it would create a central … | Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) | 90000 | 0 | 0 | 2019-04-16T15:40:56.960000-04:00 | |
| 2267855 | WINNING STRATEGIES WASHINGTON 60e45483-8968-4b1d-b299-91beac208dd9 | Q1 | WINNING STRATEGIES WASHINGTON | 50796 | I AM ALS | 2019 | first_quarter | MED | Funding for ALS research in annual Defense and Labor-HHS-Education appropriations bills | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2019-04-16T15:53:15.863000-04:00 | |
| 2267874 | HOLLAND & KNIGHT LLP 944f44be-2f11-4e08-87e4-185e0c9780e5 | Q1 | HOLLAND & KNIGHT LLP | 18466 | PUBLIC ACCESS TO SUNSCREENS (PASS) COALITION | 2019 | first_quarter | MED | Over the counter drug approval process for sunscreen ingredients; Implementation of Public Law 113-195, the Sunscreen Innovation Act; House and Senate FY 2020 Ag-FDA Appropriations bills and reports on sunscreen use in schools; Sunscreen provisions in H.R. 269, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019; issues related to state bans on sunscreen ingredients. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2019-04-16T15:59:23.523000-04:00 | |
| 2267915 | THE CORMAC GROUP, LLC 8648dd7e-1197-40cc-bb38-3bcfd9912432 | Q1 | THE CORMAC GROUP, LLC | 66773 | KESSLER FOUNDATION | 2019 | first_quarter | MED | Appropriations, DOD, TBI research, Veterans Issues | Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2019-04-16T16:16:38.780000-04:00 | |
| 2268076 | EFB ADVOCACY, LLC 730702f7-46f9-4e20-9529-693effa13b5f | Q1 | EFB ADVOCACY, LLC | 401104430 | UNITED FOR MEDICAL RESEARCH | 2019 | first_quarter | MED | Funding Issues Related to the National Institutes of Health | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2019-04-16T18:19:01.643000-04:00 | |
| 2268180 | THE FEDERAL GROUP, INC. 5f32568e-d714-4acd-bde8-a6a7b4b260a2 | Q1 | THE FEDERAL GROUP, INC. | 51104 | ASSOCIATION OF CLINICAL RESEARCH PROFESSIONALS | 2019 | first_quarter | MED | Clinical research professional training standards | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 10000 | 0 | 0 | 2019-04-17T01:43:52.263000-04:00 | |
| 2268290 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. d621819e-5f6d-4d61-91d3-ed89e5b9313b | Q1 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | ASSOCIATION FOR MOLECULAR PATHOLOGY | 2019 | first_quarter | MED | Regulation of laboratory diagnostics HR 5062, Advancing Access to Precision Medicine Act No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2019-04-17T09:52:01.320000-04:00 | |
| 2268439 | CITIZENS FOR THE EXTENSION OF THE JAMES ZADROGA ACT, INC. 2c41c965-43d3-4586-b62b-f28170e79983 | Q1 | CITIZENS FOR THE EXTENSION OF THE JAMES ZADROGA ACT, INC. | 401103403 | CITIZENS FOR THE EXTENSION OF THE JAMES ZADROGA ACT, INC. | 2019 | first_quarter | MED | Lobbying on behalf of sick and injured 9/11 responders, survivors and their families, specifically on fully funding and extending the September 11th Victim Compensation Fund through the "Never Forget the Heroes: Permanent Authorization of the September 11th Victim Compensation Fund Act," H.R. 1327, S. 546. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2019-04-17T10:48:57.870000-04:00 | |
| 2268532 | MCDERMOTT WILL & SCHULTE LLP c819e03e-f936-4663-9853-48269db39182 | Q1 | MCDERMOTT WILL & SCHULTE LLP | 24338 | MAYO CLINIC | 2019 | first_quarter | MED | Issues impacting academic medical centers. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2019-04-17T11:04:23.837000-04:00 | |
| 2268584 | THORN RUN PARTNERS db2dc9e8-0fc0-465b-b2ad-92f0c72fe779 | Q1 | THORN RUN PARTNERS | 400534596 | CONTINUING MEDICAL EDUCATION COALITION | 2019 | first_quarter | MED | Issues related to the promotion of continuing medical education (CME) and the implementation of the Physician Payment Sunshine Act. Implementation issues related to the Medicare Access and CHIP Reauthorization Act of 2015, P.L.114-10. Issues related to the role of continuing medical education (CME) and Food and Drug Administration (FDA) opioid REMS; Expressing the sense of Congress on the need to improve and expand training for future physicians on properly treating pain and prescribing opioids, and for other purposes (H.Con.Res.8). | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2019-04-17T11:15:47.707000-04:00 | |
| 2268598 | THE CORMAC GROUP, LLC 1720f4b8-8754-4530-b649-b110b1bcde4c | Q1 | THE CORMAC GROUP, LLC | 66773 | HEARTFLOW, INC. | 2019 | first_quarter | MED | Medicare payment issues | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2019-04-17T11:17:52.553000-04:00 | |
| 2268786 | THORN RUN PARTNERS 2962b1b3-4ed6-48fb-8ad9-6c8b050dfc97 | Q1 | THORN RUN PARTNERS | 400534596 | CYSTIC FIBROSIS FOUNDATION | 2019 | first_quarter | MED | Supporting National Institutes of Health (NIH) research that benefits people with cystic fibrosis. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2019-04-17T11:41:51.997000-04:00 | |
| 2269294 | AMFAR THE FOUNDATION FOR AIDS RESEARCH f509bb78-16b4-47ac-b3e8-2a4c6826e47e | Q1 | AMFAR THE FOUNDATION FOR AIDS RESEARCH | 2398 | AMFAR THE FOUNDATION FOR AIDS RESEARCH | 2019 | first_quarter | MED | Issues related to hepatitis C testing and reporting, HIV research, NIH research | Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA) | 100000 | 0 | 0 | 2019-04-17T13:11:53.497000-04:00 | |
| 2269308 | SUSAN B ANTHONY LIST e7866981-1782-4e5d-be26-c9f4a163d474 | Q1 | SUSAN B ANTHONY LIST | 400935704 | SUSAN B ANTHONY LIST | 2019 | first_quarter | MED | Bioethics - embryos, fetal tissue regulations | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,State, Dept of (DOS),White House Office | 270000 | 0 | 0 | 2019-04-17T13:12:56.170000-04:00 | |
| 2269332 | SIDLEY AUSTIN LLP b29db27b-fb58-444d-b7ee-d71c16fa532d | Q1 | SIDLEY AUSTIN LLP | 35230 | CORD BLOOD ASSOCIATION | 2019 | first_quarter | MED | Legislative and Federal agency activities related to the Stem Cell Therapeutic and Research Reauthorization Act of 2015. | Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA) | 20000 | 0 | 0 | 2019-04-17T13:19:07.613000-04:00 | |
| 2269447 | ISEMAN & ASSOCIATES LLC f8112e29-9c2b-466f-9aee-736b717cd66b | Q1 | ISEMAN & ASSOCIATES LLC | 401103582 | TICHENOR VENTURES, LLC | 2019 | first_quarter | MED | Monitoring biotech legislation | HOUSE OF REPRESENTATIVES,SENATE | 12500 | 0 | 0 | 2019-04-17T13:49:00.107000-04:00 | |
| 2270008 | GOVERNMENT COUNSEL, LLC 6245726a-1e85-4768-a353-76c64bd65d1d | Q1 | GOVERNMENT COUNSEL, LLC | 401105070 | HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) | 2019 | first_quarter | MED | The Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2018 | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2019-04-17T15:34:29.703000-04:00 | |
| 2270103 | TRAVERE THERAPEUTICS 6eb39afe-b211-459c-84c7-b195dd99c2ae | Q1 | TRAVERE THERAPEUTICS | 401104190 | TRAVERE THERAPEUTICS | 2019 | first_quarter | MED | Medical research, NIH funding, related appropriations issues | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 280000 | 0 | 0 | 2019-04-17T15:52:10.077000-04:00 | |
| 2270217 | THORN RUN PARTNERS de802965-d49c-429e-86c1-9a42deb22dad | Q1 | THORN RUN PARTNERS | 400534596 | NOVARTIS CORPORATION | 2019 | first_quarter | MED | Issues related to biologics. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2019-04-17T16:09:49.013000-04:00 | |
| 2270413 | OREGON HEALTH & SCIENCE UNIVERSITY 167839ae-5a59-49f3-aa3c-3eb43a0a8b75 | Q1 | OREGON HEALTH & SCIENCE UNIVERSITY | 30291 | OREGON HEALTH & SCIENCE UNIVERSITY | 2019 | first_quarter | MED | Impact of Budget Control Act of 2011s Sequestration on medical records; use of animals in biomedical research; moving medical research from bench to beside more quickly including greater sharing of research data, reducing administrative burden on medical researchers, streamline of clinical trials, increased flexibility in the FDAs approval process for drugs and devices tired with additional review in post-market: 21st Century Cures Act (H.R> 34); FDA regulation of mitochondrial replacement therapy Sections 736 in Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017 (H.R. 5054/S. 2956); importance of research using fetal tissue; importance of Small Business Innovation Research and Small Technology Transfer Research Program; FDA regulation of laboratory developed test. | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2019-04-17T16:58:56.620000-04:00 | |
| 2270557 | WASHINGTON UNIVERSITY IN ST. LOUIS c8864cc0-2255-4a8c-8b45-af7a5de676d5 | Q1 | WASHINGTON UNIVERSITY IN ST. LOUIS | 40031264 | WASHINGTON UNIVERSITY IN ST LOUIS | 2019 | first_quarter | MED | General advocacy for NIH and other biomedical research. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2019-04-17T18:09:46.590000-04:00 | |
| 2270768 | SQUIRE PATTON BOGGS 08279aed-8d72-4a27-b457-3e1840b908a1 | Q1 | SQUIRE PATTON BOGGS | 30906 | THOMAS JEFFERSON UNIVERSITY | 2019 | first_quarter | MED | Advancing health system legislative and regulatory issues including: the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2019-04-18T08:05:26.873000-04:00 | |
| 2270856 | PARALYZED VETERANS OF AMERICA 45dc81d6-d7f8-46bc-98f0-740a8752e308 | Q1 | PARALYZED VETERANS OF AMERICA | 30724 | PARALYZED VETERANS OF AMERICA | 2019 | first_quarter | MED | Department of Veterans Affairs, Medical Research Issues National Institutes of Health, Medical Research Issues | AMTRAK - Natl Railroad Passenger Corporation,HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Justice, Dept of (DOJ),Labor, Dept of (DOL),Natl Institutes of Health (NIH),SENATE,Transportation, Dept of (DOT),Veterans Affairs, Dept of (VA) | 77998 | 0 | 0 | 2019-04-18T08:51:53.787000-04:00 | |
| 2270881 | AMERICAN PHYSICAL THERAPY ASSOCIATION 73868323-5512-4e31-ae78-d5e35f456793 | Q1 | AMERICAN PHYSICAL THERAPY ASSOCIATION | 3093 | AMERICAN PHYSICAL THERAPY ASSOCIATION | 2019 | first_quarter | MED | NIH Rehab issues APTA role with NIH Traumatic brain injury research Support of work done at CDC Injury Center on elder adult falls, TBI, youth sports concussions NIH Research and Development funding Physical Therapist role in childhood obesity Relocate TBI State Grant Program to ACL NIDILRR - Rehab research Nomination to NIH Committees Safety of Children in School (Restraint & Seclusion) | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Education, Dept of,Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA),Social Security Administration (SSA),Veterans Affairs, Dept of (VA),White House Office | 243000 | 0 | 0 | 2019-04-18T08:55:57.400000-04:00 | |
| 2271296 | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) b207cd2e-64d5-4407-abb9-0ea485a3db43 | Q1 | FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) | 86196 | COLOR HEALTH (FKA COLOR GENOMICS) | 2019 | first_quarter | MED | Lobbying related to healthcare issues. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2019-04-18T09:57:13.110000-04:00 | |
| 2271336 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 73a96ff6-f180-46c6-a9c3-cbaab15c5868 | Q1 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | NATIONAL HEMOPHILIA FOUNDATION | 2019 | first_quarter | MED | Hemophilia research, prevention, surveillance and service programs and issues | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 50000 | 0 | 0 | 2019-04-18T10:05:26.900000-04:00 | |
| 2271460 | BRACEWELL LLP aaeade7a-672a-4761-aa2a-51586463c106 | Q1 | BRACEWELL LLP | 6837 | NATIONAL BRAIN TUMOR SOCIETY | 2019 | first_quarter | MED | work related to the advancement of the Cancer Drug Coverage Parity Act and STAR Act | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2019-04-18T10:30:18.360000-04:00 | |
| 2271603 | CORNERSTONE GOVERNMENT AFFAIRS, INC. 8eebcde5-3558-4358-954c-633a32b72deb | Q1 | CORNERSTONE GOVERNMENT AFFAIRS, INC. | 75557 | CITY OF HOPE MEDICAL CENTER | 2019 | first_quarter | MED | Medicare/Medicaid reimbursement, clinical research | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2019-04-18T10:45:05.217000-04:00 | |
| 2271801 | AMERICAN CLINICAL LABORATORY ASSN 2e8dbd73-df3b-4ec2-8326-115e4760ffb5 | Q1 | AMERICAN CLINICAL LABORATORY ASSN | 1923 | AMERICAN CLINICAL LABORATORY ASSN | 2019 | first_quarter | MED | regulation and oversight of clinical laboratories, including laboratory developed test services, the Diagnostic Accuracy and Innovation Act discussion draft and Verifying Accurate, Leading-edge IVCT Development Act discussion draft; reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, physician fee schedule, new test coding and pricing, TRICARE coverage and reimbursement, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); narrowing the in-office ancillary services exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy; Medicare physician signature documentation requirements; National Diabetes Prevention Program; commercial laboratory surge capacity issues for response to pandemic/epidemic/public health crises, Anti-Kickback Law relating to clinical laboratories. Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2020; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2020; Medicare reimbursement of clinical laboratory services;SUPPORT for Patients and Communities Act (PL 115-271). | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Office of Management & Budget (OMB),SENATE,White House Office | 170793 | 0 | 0 | 2019-04-18T11:16:25.057000-04:00 | |
| 2271993 | BALLARD PARTNERS ba37b4bb-686f-4a7e-bf0d-d1efec468164 | Q1 | BALLARD PARTNERS | 401104288 | LABORATORY CORPORATIONS OF AMERICA HOLDINGS | 2019 | first_quarter | MED | Clinical Lab Rates | Health & Human Services, Dept of (HHS),White House Office | 80000 | 0 | 0 | 2019-04-18T11:37:36.183000-04:00 | |
| 2272359 | KANSAS STATE UNIVERSITY 66c13f8e-3f8d-450a-acfb-62bb5f77d33f | Q1 | KANSAS STATE UNIVERSITY | 401104168 | KANSAS STATE UNIVERSITY | 2019 | first_quarter | MED | cancer research and public health issues | Agriculture, Dept of (USDA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE | 221176 | 0 | 0 | 2019-04-18T12:39:01.380000-04:00 | |
| 2272423 | THE JACKSON LABORATORY fa6be5ed-5ec0-45bc-8dda-7d5c6cd01f21 | Q1 | THE JACKSON LABORATORY | 401104723 | THE JACKSON LABORATORY | 2019 | first_quarter | MED | Issues pertaining to basic science research and biomedical research. | HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT) | 30000 | 0 | 0 | 2019-04-18T12:48:22.840000-04:00 | |
| 2272672 | HANCE SCARBOROUGH 051fca8e-11a1-46df-801c-4e52908c2aab | Q1 | HANCE SCARBOROUGH | 17443 | TITAN PHARMACEUTICALS, INC. | 2019 | first_quarter | MED | Medicare/Medicaid drug coverage, opioid addiction policy. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2019-04-18T13:21:36.653000-04:00 | ||
| 2273128 | THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) 22d59b98-96c2-4183-b074-dd1515de79a4 | Q1 | THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) | 2970 | THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) | 2019 | first_quarter | MED | Support for Heart and Lung Research in the FY 2020 LHHS bill (no bill number). Support for Increased funding for SAMHSA and HRSA programs in the FY 2020 LHHS bill (no bill number). Support for designating a stand-alone arthritis program within the Congressionally Directed Medical Research Program (CDMRP) at the Department of Defense, funded at $20 million for FY 2020 (no bill number). | Education, Dept of,HOUSE OF REPRESENTATIVES,SENATE | 200000 | 0 | 0 | 2019-04-18T14:36:33.147000-04:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);